January 17, 2017 7:08 PM ET

Biotechnology

Company Overview of Protea Biosciences Group, Inc

Company Overview

Protea Biosciences Group, Inc., a molecular information company, develops and commercializes proprietary life science technologies, products, and services to identify the molecules that are produced by living cells and various life forms. The company provides molecular information services for the identification of small and large molecules; and services in the areas of mass spectrometry imaging (MSI), proteomics, metabolomics, lipidomics, and bioinformatics. It also offers laser ablation electrospray ionization, a bioanalytical instrument platform that enables the identification of proteins, lipids, and metabolites in tissue, cells, and biofluids, such as serum and urine. It primarily serve...

1311 Pineview Drive

Suite 501

Morgantown, WV 26505

United States

Founded in 2001

35 Employees

Phone:

304-292-2226

Fax:

304-292-7101

Key Executives for Protea Biosciences Group, Inc

Chairman and Chief Executive Officer
Age: 70
Total Annual Compensation: $240.0K
Chief Science Officer and Vice President of Research & Development
Age: 41
Total Annual Compensation: $186.0K
Consultant
Age: 47
Total Annual Compensation: $210.0K
Compensation as of Fiscal Year 2015.

Protea Biosciences Group, Inc Key Developments

Protea Biosciences Group, Inc. Announces Marketing Partnership with MatTek Corp

Protea Biosciences Group Inc. announced that the company has entered into a co-marketing agreement with MatTek Corporation, which allows Protea to include MatTek’s human cell based in vitro tissue models with Protea’s proprietary molecular imaging services.

Protea Biosciences Group, Inc Reports Earnings Results for the Third Quarter and Nine Months Ended Sept. 30, 2016

Protea Biosciences Group Inc. reported earnings results for the third quarter and nine months ended Sept. 30, 2016. For the quarter, the company reported revenue of $519,908. The net loss for the third quarter of 2016 was $1,494,790, a decrease of 6% compared to the third quarter of 2015. Net cash used in operations was $568,194 a reduction of 46% in comparison to the third quarter of 2015. For the nine months, revenue of $1,577,010, an increase of 24% over the first nine months of 2015. The loss from operations for the first nine months of 2016 was $4,496,322, a 19% reduction compared to the first nine months of 2015. Net cash used in operating activities for the nine months ended September 30, 2016 totaled $3,408,885, a 21% reduction in the net cash used in operations in comparison to the first nine months of 2015.

Protea Biosciences Group, Inc announced delayed 10-Q filing

On 11/15/2016, Protea Biosciences Group, Inc announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
October 31, 2016
--
Private Placement
September 8, 2016
--
Private Placement
May 20, 2016
--
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Protea Biosciences Group, Inc, please visit www.proteabio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.